Company / Return on Equity (ROE)
Pulmonx Corp Return on Equity (ROE) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-65.7%
FY2025
5-year range
-65.7% / -14.2%
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Pulmonx Corp reports negative total equity of -65.7% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-65.7% in FY2025 with a 3-year CAGR of -40.5%.
Declined from -38.3% to -65.7% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -40.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Pulmonx Corp's return on equity (roe) has declined for 4 consecutive years.
- In FY2025, return on equity (roe) decreased 27.8% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -65.7% | -27.8% |
| FY2024 | -51.4% | -34.4% |
| FY2023 | -38.3% | -51.9% |
| FY2022 | -25.2% | -76.7% |
| FY2021 | -14.2% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026